This Antibody Drug Is Likely Effective Against Omicron

This Antibody Drug Is Likely Effective Against Omicron
SHARE

The Omicron covid variant has been making headlines a lot lately. Check out the latest reports that have been revealed by The Wall Street Journal.

It’s been revealed that early laboratory studies suggest that a Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. is effective against the Omicron variant.

This sets it apart from similar therapies that appear to work less well against the highly mutated strain.

According to the online publication, the companies said Thursday that they had tested the drug, called sotrovimab, against certain individual mutations found in Omicron, which has now been detected in at least 24 countries, including the U.S.

Credit: Pixabay.com
Credit: Pixabay.com

The same article mentioned above notes the fact that Glaxo and Vir said the findings were “preliminary and they would need to test the treatment against the whole of the mutated spike protein found in the variant to confirm the result.”

Controversial covid measures

There are some measures that are taken in various countries regarding covid vaccines that are making some people outraged. The latest reports coming from Greece are such an example.

Check out the latest news about the issue below.

BBC just reported that Greece would be making covid vaccinations mandatory for people aged 60 and over.

Fines of €100 will be imposed at monthly intervals from mid-January on those who refuse, Prime Minister Kyriakos Mitsotakis said.

BBC also noted that the money would go towards the Greek health system. Just in case you don’t know, their system is struggling with a surge in hospital admissions.

It’s been revealed that a lot of countries have made vaccines mandatory for health workers and other high-risk workers, but Greece will become the first in the EU to target a specific age group.

Another thing worth mentioning is that Austria has announced that compulsory Covid vaccinations will start in February.


SHARE
Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.